Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells
Keyword(s):
T Cell
◽
Keyword(s):
2012 ◽
Vol 61
(10)
◽
pp. 1745-1753
◽
1993 ◽
Vol 7
(2)
◽
pp. 144-153
◽
2019 ◽
Vol 7
◽
1987 ◽
Vol 148
(2)
◽
pp. 415-417
◽
Keyword(s):
1995 ◽
Vol 42
(5)
◽
pp. 505-511
◽